• Home
  • About Us
    • Who we are
    • Our Early History
    • Technology
    • Target Markets
      • Venous and pressure ulcers
      • Other Applications
    • Business Model
    • Licensing
    • Clinical Trial
    • Publications & Presentations
    • Company Milestones
    • Focus
  • The Company
    • Board & Management
      • Paul Wright
      • Mark Richardson
      • George Baumanis
      • Stuart Usher
  • Advisory Team
    • Intellectual Property
      • Vaughan Barlow
      • Tom Boyce
      • Audrey Yap
      • Yvette Flanigan
    • Principal Advisor
      • Mark Woolley
    • Medical and Scientific Advisory Committee
      • James Fries
      • Michael Woodward
    • Scientific
      • Richard Lipscombe
    • Clinical
      • Geoffrey Mitchell
    • Health Economics
      • Nicholas Graves
  • Media
  • Links
  • Members Log in
  • Contact Us

News Headlines

> 18/01/10
Phoenix Eagle commences clinical trial.


> 01/12/09
OPAL A-1001 clinical trial has been approved by the Human Research Ethics Committee of the Austin Hospital.

The Phoenix Eagle Advisory Team

Intellectual Property - Tom Boyce

Intellectual Property - Tom Boyce

Tom Boyce, PhD, is responsible for Phoenix Eagle’s United States patent portfolio. Tom is also a partner at Pizzeys. His unique background and experience in patent law across several jurisdictions is an important asset and Tom is particularly valued for his expertise in understanding the requirements for the drafting and prosecution of patent applications in the US. Tom holds a PhD in the field of evolutionary genetics.

The Phoenix Eagle Company Pty Ltd website is proudly maintained by NetBiz Enterprises.